American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (986)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1255)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3997)
  2. Hematologic Malignancies, Division of (3800)
  3. Center for Hematologic Malignancies (3677)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (62)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5172)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5553)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Artificial-intelligence, data-driven, comprehensive classification of myeloid neoplasms based on genomic, morphological and histological features
    Meeting Abstract

    Lanino, L.; D'Amico, S.; Maggioni, G.; Ali, N. H. A.; Wang, Y. H.; Gurnari, C.; Gagelmann, N.; Bewersdorf, J. P.; Ball, S.; Guglielmelli, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Increased inflammatory cytokines in plasma are associated with sustained treatment-free remission in chronic myeloid leukaemia
    Meeting Abstract

    Kok, C. H.; Saunders, V. A.; Shanmuganathan, N.; Liu, L.; Irani, Y. D.; Clarson, J.; Dang, P.; Yeung, D. T.; Yong, A. S. M.; Branford, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Survival and therapeutic outcomes in T-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort
    Meeting Abstract

    Braunstein, Z.; McLaughlin, E.; Lingamaneni, P.; Barta, S. K.; Cao, M.; Chang, T.; Ganesan, N.; Luu, B.; Mehta-Shah, N.; Shree, T.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Systematic evaluation of GAPs and GEFs identifies ARHGAP45 as a targetable leukemia-specific dependency
    Meeting Abstract

    Zhang, P.; Cao, Z.; Pan, X.; Liu, Y.; Castro, C.; Kim, W. J.; Fujino, T.; Lewis, J.; Rahman, J.; Shahid, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Results from the first phase 1 clinical study of DR-01, a non-fucosylated anti-CD94 targeting antibody in patients with relapsed/refractory cytotoxic lymphomas: Dose escalation and optimization
    Meeting Abstract

    Zain, J.; Iyer, S. P.; Marchi, E.; Gandhi, M.; Kim, Y. H.; Khodadoust, M. S.; Brammer, J. E.; Poh, C.; Porcu, P.; Dilley, K.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Obecabtagene autoleucel (obe-cel) for adult relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL): Deep molecular remission may predict better outcomes
    Meeting Abstract

    Jabbour, E.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Sandhu, K. S.; Abedi, M.; Shah, B. D.; Bishop, M. R.; DeAngelo, D. J.; Lao-Sirieix, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Leukemia evolution and resistance to graft-versus-leukemia responses revealed by mitochondrial DNA mutations
    Meeting Abstract

    Penter, L.; Cieri, N.; Maurer, K.; Kwok, M.; Lyu, H.; Lu, W. S.; Oliveira, G.; Gohil, S. H.; Leshchiner, I.; Lareau, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative safety and efficacy of ciltacabtagene autoleucel and idecabtagene vicleucel CAR T-cell therapies in relapsed or refractory multiple myeloma
    Meeting Abstract

    Hansen, D. K.; Peres, L. C.; Dima, D.; Richards, A.; Shune, L. O.; Afrough, A.; Midha, S.; Dhakal, B.; Kocoglu, M. H.; Atrash, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Pre-apheresis prediction of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma
    Meeting Abstract

    Rejeski, K.; Hansen, D. K.; Cordas Dos Santos, D. M.; De Menezes Silva Corraes, A.; Castaneda, O.; Dillard, C. M.; Alsdorf, W.; Frenking, J. H.; Purcarea, A.; Chhabra, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Preliminary efficacy and safety of the Bruton tyrosine kinase degrader BGB-16673 in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: Results from the phase 1 CaDAnCe-101 study
    Meeting Abstract

    Thompson, M. C.; Parrondo, R. D.; Frustaci, A. M.; Allan, J. N.; Ghia, P.; Mocanu, I.; Tam, C. S.; Trotman, J.; Ahn, I. E.; Stilgenbauer, S.; more...
    Blood (2024)

    Fulltext@MSK | Save